JP2025512066A5 - - Google Patents
Info
- Publication number
- JP2025512066A5 JP2025512066A5 JP2024560463A JP2024560463A JP2025512066A5 JP 2025512066 A5 JP2025512066 A5 JP 2025512066A5 JP 2024560463 A JP2024560463 A JP 2024560463A JP 2024560463 A JP2024560463 A JP 2024560463A JP 2025512066 A5 JP2025512066 A5 JP 2025512066A5
- Authority
- JP
- Japan
- Prior art keywords
- mrna agent
- human
- cells
- stem cells
- evs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263331532P | 2022-04-15 | 2022-04-15 | |
| US63/331,532 | 2022-04-15 | ||
| PCT/IB2023/000204 WO2023199113A1 (en) | 2022-04-15 | 2023-04-13 | COMPOSITIONS AND METHODS FOR EXOSOME-MEDIATED DELIVERY OF mRNA AGENTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512066A JP2025512066A (ja) | 2025-04-16 |
| JP2025512066A5 true JP2025512066A5 (https=) | 2026-04-17 |
Family
ID=86771485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560463A Pending JP2025512066A (ja) | 2022-04-15 | 2023-04-13 | エキソソームを介したｍＲＮＡ剤の送達のための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230330264A1 (https=) |
| EP (1) | EP4507701A1 (https=) |
| JP (1) | JP2025512066A (https=) |
| KR (1) | KR20250004778A (https=) |
| AU (1) | AU2023254488A1 (https=) |
| CA (1) | CA3247667A1 (https=) |
| IL (1) | IL316370A (https=) |
| WO (1) | WO2023199113A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026017857A1 (en) | 2024-07-18 | 2026-01-22 | Smartcella Solutions Ab | Treatment of osteoarthritis and/or rheumatoid arthritis with pro-chondrogenic and/or chondrocyte protective factors |
| WO2026017864A1 (en) | 2024-07-18 | 2026-01-22 | Smartcella Solutions Ab | Treatment of osteoarthritis and/or rheumatoid arthritis with pro-chondrogenic and/or chondrocyte protective factors |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US5994619A (en) | 1996-04-01 | 1999-11-30 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Production of chimeric bovine or porcine animals using cultured inner cell mass cells |
| US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
| WO2003062404A1 (en) | 2002-01-25 | 2003-07-31 | Gamida-Cell Ltd. | Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
| EP2291213B1 (en) | 2008-04-08 | 2015-08-19 | SmartWise Sweden AB | Endoluminal medical access device |
| WO2012004165A1 (en) | 2010-07-08 | 2012-01-12 | Karolinska Institutet Innovations Ab | Novel endoluminal medical access device |
| EP2625189B1 (en) | 2010-10-01 | 2018-06-27 | ModernaTX, Inc. | Engineered nucleic acids and methods of use thereof |
| WO2013103659A1 (en) | 2012-01-04 | 2013-07-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus |
| SG11201408717XA (en) | 2012-06-26 | 2015-02-27 | Seraxis Inc | Stem cells and pancreatic cells useful for the treatment of insulin-dependent diabetes mellitus |
| WO2014093924A1 (en) | 2012-12-13 | 2014-06-19 | Moderna Therapeutics, Inc. | Modified nucleic acid molecules and uses thereof |
| PL2922554T3 (pl) | 2012-11-26 | 2022-06-20 | Modernatx, Inc. | Na zmodyfikowany na końcach |
| US20160022840A1 (en) | 2013-03-09 | 2016-01-28 | Moderna Therapeutics, Inc. | Heterologous untranslated regions for mrna |
| EP2968391A1 (en) | 2013-03-13 | 2016-01-20 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| CN120796168A (zh) | 2013-06-11 | 2025-10-17 | 哈佛学院校长同事会 | SC-β细胞以及用于产生其的组合物和方法 |
| MA40589A (fr) | 2014-08-22 | 2017-06-28 | Procella Therapeutics Ab | Utilisation de jagged 1/frizzled 4 à titre de marqueurs de surface cellulaire pour isoler des cellules progénitrices ventriculaires cardiaques humaines |
| US10596200B2 (en) | 2014-08-22 | 2020-03-24 | Procella Therapeutics Ab | Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells |
| WO2016100921A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF |
| CN107614678B (zh) | 2014-12-18 | 2021-04-30 | 哈佛学院校长同事会 | 干细胞来源的β细胞的产生方法及其使用方法 |
| WO2016100898A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof |
| WO2016100925A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | METHODS FOR GENERATING AUGMENTED STEM CELL-DERIVED β CELLS AND USES THEREOF |
| US11160834B2 (en) * | 2015-04-28 | 2021-11-02 | The Texas A&M University System | Scalable production of standardized extracellular vesicles, extracellular vesicle preparations and uses thereof |
| EP3291822A1 (en) | 2015-05-05 | 2018-03-14 | Katholieke Universiteit Leuven | Improved methods for pancreatic islet transplantation |
| CN107921148A (zh) | 2015-05-08 | 2018-04-17 | 哈佛学院校长同事会 | 通用供体干细胞和相关方法 |
| WO2017075708A1 (en) * | 2015-11-05 | 2017-05-11 | Exerkine Corporation | Exosomes useful to treat cystic fibrosis |
| US10508263B2 (en) | 2016-11-29 | 2019-12-17 | Procella Therapeutics Ab | Methods for isolating human cardiac ventricular progenitor cells |
| WO2019038587A1 (en) | 2017-08-23 | 2019-02-28 | Procella Therapeutics Ab | USE OF NEUROPILIN-1 (NRP1) AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS |
-
2023
- 2023-04-13 JP JP2024560463A patent/JP2025512066A/ja active Pending
- 2023-04-13 WO PCT/IB2023/000204 patent/WO2023199113A1/en not_active Ceased
- 2023-04-13 AU AU2023254488A patent/AU2023254488A1/en active Pending
- 2023-04-13 CA CA3247667A patent/CA3247667A1/en active Pending
- 2023-04-13 KR KR1020247037694A patent/KR20250004778A/ko active Pending
- 2023-04-13 IL IL316370A patent/IL316370A/en unknown
- 2023-04-13 US US18/134,443 patent/US20230330264A1/en active Pending
- 2023-04-13 EP EP23730883.8A patent/EP4507701A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liang et al. | Development and delivery systems of mRNA vaccines | |
| JP6881813B2 (ja) | 核酸ワクチン | |
| Liu et al. | Small extracellular vesicles: Yields, functionalization and applications in diabetic wound management | |
| JP2025512066A5 (https=) | ||
| Yang et al. | Microneedle-assisted vaccination combined with autophagy regulation for antitumor immunotherapy | |
| Wang et al. | A combination of PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted microbubble destruction for tumor immunotherapy | |
| Han et al. | Hitchhiking on controlled-release drug delivery systems: opportunities and challenges for cancer vaccines | |
| JP2018522593A5 (https=) | ||
| JP2019514416A (ja) | 間葉系幹細胞と筋損傷及び筋肉関連疾患の治療のための間葉系幹細胞の使用 | |
| CN102596179A (zh) | 脂质体组合物及其用途 | |
| JP6750782B2 (ja) | 移植用幹細胞及びその製造方法 | |
| WO2022228469A1 (zh) | 聚合物囊泡纳米sting激动剂及其制备方法与应用 | |
| BR112012019267B1 (pt) | Composição englobando célula dendrítica (dc) madura próinflamatória, e uso da dita célula | |
| IL316370A (en) | COMPOSITIONS AND METHODS FOR EXOSOME-MEDIATED DELIVERY OF mRNA AGENTS | |
| Nie et al. | A single-shot prophylactic tumor vaccine enabled by an injectable biomembrane hydrogel | |
| Zhu et al. | An mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite for cancer immunotherapy | |
| Zhang et al. | Advances and Strategies in Enhancing mRNA Cancer Vaccines | |
| CN116870174A (zh) | 一种dna四面体复合物及其在制备治疗银屑病的药物中的用途 | |
| CN114848610A (zh) | 一种外泌体-vegf-a纳米药物及其制备方法和应用 | |
| CN118141903B (zh) | 一种治疗犬黑色素瘤的环状rna疫苗 | |
| Yang et al. | Novel bionic inspired nanosystem construction for precise delivery of mRNA | |
| Zhang et al. | Engineered probiotics recruit CAR macrophages and establish immune memory to eradicate heterogeneous glioblastoma in mice | |
| CN115463081A (zh) | 一种含酵母基因工程细胞的3d仿生植入体的制备与应用 | |
| Elangovan et al. | The oral and craniofacial relevance of chemically modified RNA therapeutics | |
| CN117024568A (zh) | 一种atp响应型疫苗功能化框架核酸及其应用 |